Overview
Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients.
Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Wilms Tumor, Hormone Replacement Therapy (HRT), and Prostatectomy.
His clinical research consists of co-authoring 74 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Testicular Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5255 Loughboro Road Northwest, Building B, Building B, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Nirmish Singla is an Oncologist in Lutherville, Maryland. Dr. Singla is rated as an Elite provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy.
Mark Greene is an Oncologist in Rockville, Maryland. Dr. Greene is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Testicular Cancer, Ovarian Cancer, Breast Cancer, Breast Cancer in Men, and Salpingo-Oophorectomy.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Mohamad Allaf is Professor of Urology and Oncology, as well as Director of the Department of Urology and the Brady Urological Institute and Urologist-in-Chief of the Johns Hopkins Hospital. Dr. Allaf is a world renowned surgeon-scientist having performed more than 2,000 robotic procedures and published over 250 peer reviewed research papers in the field's best journals. As one of the busiest robotic radical prostatectomy surgeons in the world, he aims to achieve the best outcomes for his patients. Having trained with Dr. Patrick Walsh, Dr. Allaf has used Dr. Walsh's method of radical prostatectomy as the basis for his own anatomic method to this complex operation. Dr. Allaf is also amongst the leaders in kidney cancer surgery, having served on the American Urological Association Guideline Committee for Kidney Cancer. He led a team who performed the rigorous analysis to help inform the most recent guidelines that was funded by the Agency for Healthcare Research and Quality (AHRQ). He is best known for his ability to save the kidney and remove the tumor in patients with kidney tumors. Dr. Allaf runs a research endeavor aiming to decrease the morbidity associated with the treatment of cancer, and he has mentored numerous leaders in academic urology. He is actively involved in fund raising for research and education, and believes in expanding our base of support in order to advance our important mission. Dr. Allaf is rated as an Elite provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Renal Oncocytoma, Prostate Cancer, Nephrectomy, and Prostatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Hormone Replacement Therapy (HRT)Dr. Markowski isElite. Learn about Hormone Replacement Therapy (HRT).
- Prostate CancerDr. Markowski isElite. Learn about Prostate Cancer.
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Markowski isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Markowski isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Markowski isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Markowski isDistinguished. Learn about Familial Wilms Tumor 2.
- Renal Cell Carcinoma (RCC)Dr. Markowski isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Wilms TumorDr. Markowski isDistinguished. Learn about Wilms Tumor.
- Advanced
- Adult Soft Tissue SarcomaDr. Markowski isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- NUT CarcinomaDr. Markowski isAdvanced. Learn about NUT Carcinoma.
- ProstatectomyDr. Markowski isAdvanced. Learn about Prostatectomy.
- Experienced
- Alveolar Soft Part SarcomaDr. Markowski isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Bladder CancerDr. Markowski isExperienced. Learn about Bladder Cancer.
- Bone TumorDr. Markowski isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Markowski isExperienced. Learn about Brain Tumor.
- Metastatic Brain TumorDr. Markowski isExperienced. Learn about Metastatic Brain Tumor.
- Muscle Invasive Bladder CancerDr. Markowski isExperienced. Learn about Muscle Invasive Bladder Cancer.